现代牙科(03600)发布公告，截至2025年9月30日止9个月，在牙科行业数码化趋势持续的支持下，本集 团的多维度策略及持续提升的营运效率及生产力，使其于本期间的收益创下纪录新高。宏观经济环境充 满挑战，牙科手术的需求普遍疲弱，且贸易战存在不确定性，然而仍然创下纪录。本集团利用位于泰 国、越南及中国内地的国际生产设施，积极应对前所未有的国际贸易环境。 中国大陆市场面临带量采购政策及长期激烈价格竞争的阻力。此举亦导致中国内地诊所积极于香港推广 种植牙治疗(香港患者就诊人数明显减少)。集团有意摆脱低利润率的市场，转而专注于服务中高价值客 户，确保集团业务的长期可持续盈利能力。 澳洲的收益取得升幅反映了牙科行业数码化趋势推动的新数码产品的强劲成长。 其他业务收益的成长主要来自2025年1月收购Hexa Ceram对泰国市场的销售贡献。Hexa Ceram的销售及 分销网络为集团提供了在泰国的广泛客户群，集团期内专注于进一步扩大和补充其产品供应、分销及销 售网络。 截至2025年9月30日止9个月，本集团的销量总数增加约29.5%至约211.5万件(截至2024年9月30日止9个 月：约163.3万件)。不包括截至 ...

澳洲的收益取得升幅反映了牙科行业数码化趋势推动的新数码产品的强劲成长。 智通财经APP讯，现代牙科(03600)发布公告，截至2025年9月30日止9个月，在牙科行业数码化趋势持续 的支持下，本集团的多维度策略及持续提升的营运效率及生产力，使其于本期间的收益创下纪录新高。 宏观经济环境充满挑战，牙科手术的需求普遍疲弱，且贸易战存在不确定性，然而仍然创下纪录。本集 团利用位于泰国、越南及中国内地的国际生产设施，积极应对前所未有的国际贸易环境。 全球数码化趋势持续推动义齿行业的整合，使本集团进一步扩大其市场份额。我们持续的数码转型措施 提升客户及病人体验的同时，进一步使本集团在竞争对手中脱颖而出，表现优于同业。 本集团的相关基础持续稳固，并将全力以赴以进一步把握未来机遇。 截至2025年9月30日止9个月，本集团的收益总额(约27.52亿港元)较截至2024年9月30日止9个月(约25.22 亿港元)增加约9.2%。 我们位于北美当地的实验室业务MicroDental的销售取得下跌，乃受到牙科美容治疗(病人可酌情选择)的 需求不振及美国经济疲弱所影响。然而，此跌幅被我们境外生产的产品采用数码化措施后竞争力提升， ...

（於開曼群島註冊成立的有限公司） （股份代號：3600） 自願性披露 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準 確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產 生或因倚賴該等內容而引致的任何損失承擔任何責任。 2025 年第三季度更新 董事會欣然就本集團截至2025年9月30日止九個月之未經審核選定營運數據作出自 願性披露及更新。 本集團的更新 截至2025年9月30日止九個月，在牙科行業數碼化趨勢持續的支持下，本集團的多 維度策略及持續提升的營運效率及生產力，使其於本期間的收益創下紀錄新高。宏 觀經濟環境充滿挑戰，牙科手術的需求普遍疲弱，且貿易戰存在不確定性，然而仍 然創下紀錄。本集團利用位於泰國、越南及中國內地的國際生產設施，積極應對前 所未有的國際貿易環境。 全球數碼化趨勢持續推動義齒行業的整合，使本集團進一步擴大其市場份額。我們 持續的數碼轉型措施提升客戶及病人體驗的同時，進一步使本集團在競爭對手中脫 穎而出，表現優於同業。 本集團的相關基礎持續穩固，並將全力以赴以進一步把握未來機遇。 – 1 – 全球收益 截至2025年9月30日 ...

FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年10月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 現代牙科集團有限公司 (於開曼群島註冊成立的有限公司) 呈交日期: 2025年11月3日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 03600 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 3,000,000,000 | USD | | 0.01 | USD | | 30,000,000 | | 增加 / 減少 (-) | | | | | | | USD | | | | 本月底結存 | | | 3,000,000,000 | USD | | 0.01 | USD | ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年9月30日 狀態: 新提交 FF301 致：香港交易及結算所有限公司 公司名稱: 現代牙科集團有限公司 (於開曼群島註冊成立的有限公司) 呈交日期: 2025年10月2日 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 03600 | 說明 | | | | | | | | | 已發行股份（不包括庫存股份）數目 | | 庫存股份數目 | | 已發行股份總數 | | | 上月底結存 | | | 934,850,000 | | 0 | | 934,850,000 | | 增加 / 減少 (-) | | | | | | | | | 本月底結存 | | | 934,850,000 | | 0 | | 934,850,000 | 第 2 頁 共 10 頁 v 1.1.1 III.已發行股份及/或庫存股份變動詳情 I. 法定/註冊股本 ...

(Incorporated in the Cayman Islands with limited liability) （於開曼群島註冊成立的有限公司） (Stock Code 股份代號: 3600) NOTIFICATION LETTER 通知信函 Dear Non-Registered Holder (Note 1) Modern Dental Group Limited (the "Company") – Notice of publication of 2025 Interim Report ("Current Corporate Communication (Note 2) ") on the Company's website , 18 September 2025 The English and Chinese versions of the Company's Current Corporate Communications are available on the Company's website at www.moderndentalgp.com the website of The S ...

(Incorporated in the Cayman Islands with limited liability) （於開曼群島註冊成立的有限公司） (Stock Code 股份代號: 3600) NOTIFICATION LETTER 通知信函 18 September 2025 Dear Registered Shareholder, Modern Dental Group Limited (the "Company") – Notice of publication of 2025 Interim Report ("Current Corporate Communication") on the Company's website The English and Chinese versions of the Company's Current Corporate Communications are now available on the Company's website at www.moderndentalgp.com and the website of The Stock Exchan ...

Financial Performance - For the six months ending June 30, 2025, the company's revenue was approximately HKD 1,834,814,000, an increase of about HKD 132,983,000 or 7.8% compared to HKD 1,701,831,000 for the same period in 2024[12] - The gross profit margin for the same period was approximately 54.8%, up from 53.7% in the previous year, with gross profit increasing by about HKD 91,485,000 or 10.0% to HKD 1,005,476,000[12] - EBITDA for the six months ending June 30, 2025, was approximately HKD 456,711,000, representing an increase of about HKD 81,140,000 or 21.6% compared to HKD 375,571,000 in 2024[12] - Net profit for the same period was approximately HKD 288,650,000, an increase of about HKD 74,295,000 or 34.7% from HKD 214,355,000 in 2024[12] - The company declared an interim dividend of HKD 0.107 per share, compared to HKD 0.08 per share in the previous year, reflecting a strong performance[12] Market Performance - Revenue from the European market was HKD 920,255,000, a 10.9% increase from HKD 822,914,000 in 2024, while North American revenue decreased by 5.1% to HKD 365,680,000[14] - The Greater China market revenue was HKD 293,176,000, reflecting a decrease of approximately 9.8% compared to the previous period[36] - Revenue from the Australian market was approximately HKD 137,858,000, an increase of about HKD 9,956,000 compared to the previous six months, maintaining a share of about 7.5% of total revenue[42] Product Revenue Breakdown - Fixed dental equipment revenue reached approximately HKD 1,098,288,000, an increase of about HKD 52,901,000 compared to the previous period, accounting for approximately 63.6% of total customized product revenue[22] - Removable dental equipment revenue was approximately HKD 447,394,000, an increase of about HKD 53,848,000, representing approximately 25.9% of total customized product revenue[23] - Other customized equipment revenue amounted to approximately HKD 181,639,000, an increase of about HKD 38,017,000, making up approximately 10.5% of total customized product revenue[24] Acquisitions and Investments - The company completed the acquisition of Hexa Ceram, Thailand's largest dental laboratory, in January 2025, contributing approximately HKD 88.7 million to revenue for the six months ending June 30, 2025[15] - The company has made significant acquisitions, including the recent acquisition of Hexa Ceram, enhancing its distribution and sales network in Southeast Asia[45] - The acquisition of Hexa Ceram contributed to revenue growth, although it was offset by intense price competition in Greater China and weak demand in North America due to tariff pressures[47] Operational Efficiency - The company’s core business profit margin improved to 16.1%, up from 13.5% in the previous year, indicating enhanced operational efficiency[13] - Operating expenses for sales and distribution increased by approximately 3.1% to HKD 238,044,000, accounting for about 13.0% of total revenue, down from 13.6% in 2024[50] - Administrative expenses rose by approximately 10.2% to HKD 417,636,000, representing about 22.8% of total revenue, compared to 22.3% in 2024[51] Cash Flow and Financial Position - For the six months ended June 30, 2025, the net cash flow from operating activities was approximately HKD 289,742,000, an increase of 37% compared to HKD 210,840,000 for the same period in 2024[63] - The net cash outflow from investing activities for the six months ended June 30, 2025, was approximately HKD 246,137,000, significantly higher than HKD 93,477,000 for the same period in 2024, primarily due to acquisitions[64] - The net cash outflow from financing activities for the six months ended June 30, 2025, was approximately HKD 326,777,000, compared to HKD 119,413,000 for the same period in 2024, driven by debt repayments and dividend payments[65] Employee and Shareholder Information - The company has a total of 8,594 full-time employees as of June 30, 2025, an increase from 7,106 employees as of December 31, 2024[96] - Employee costs for the six months ended June 30, 2025, amounted to approximately HKD 824,628,000, compared to HKD 786,274,000 for the same period in 2024[96] - The board declared an interim dividend of HKD 0.107 per ordinary share for the six months ended June 30, 2025, up from HKD 0.080 for the same period in 2024[93] Corporate Governance and Compliance - The company has complied with the corporate governance code as per the Stock Exchange Listing Rules during the six months ending June 30, 2025[117] - The board believes that having the same individual serve as both Chairman and CEO is beneficial for the company's strategic direction and decision-making efficiency[118] Risks and Challenges - The company faces various market risks, including global economic fluctuations and geopolitical risks, which may impact financial performance[86] - The company has not entered into any interest rate agreements or derivative transactions to hedge against interest rate fluctuations[89] Share Repurchase and Capital Management - The company repurchased 5,427,000 shares at a total cost of approximately HKD 22,440,000, with an average price per share ranging from HKD 3.73 to HKD 4.28[112] - The company aims to enhance shareholder value by increasing net asset value per share and earnings per share through share repurchases[113]

FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年8月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 現代牙科集團有限公司 (於開曼群島註冊成立的有限公司) 呈交日期: 2025年9月3日 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 03600 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 3,000,000,000 | USD | | 0.01 USD | | 30,000,000 | | 增加 / 減少 (-) | | | | | | USD | | | | 本月底結存 | | | 3,000,000,000 | USD | | 0.01 USD | | 30,000,000 | 本月底法定/註冊股本總額： USD ...

Core Viewpoint - Modern Dental Group reported a revenue of HKD 1.835 billion for the six months ending June 30, 2025, representing a year-on-year increase of 7.81% [1] - The profit attributable to the company's owners was HKD 285 million, a significant year-on-year increase of 32.52% [1] - The company plans to distribute an interim dividend of HKD 0.107 per share [1] Revenue Growth Drivers - The revenue growth was primarily driven by sustained organic growth in Europe and Australia [1] - The completion of the acquisition of Thailand's largest dental laboratory, Hexa Ceram Company Limited, in January 2025 accelerated the group's growth [1]